within Pharmacolibrary.Drugs.ATC.L;

model L01XA01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0002666666666666667,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.011,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.015,
    k12             = 31,
    k21             = 31
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>L01XA01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Cisplatin is a platinum-based chemotherapy drug used principally in the treatment of various cancers including testicular, ovarian, bladder, and lung cancers. It acts by forming DNA crosslinks that inhibit DNA repair and replication, ultimately leading to cell death. Cisplatin is FDA approved and is widely used as a standard treatment option in oncology.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult cancer patients receiving cisplatin via intravenous infusion.</p><h4>References</h4><ol><li><p>Orgel, E, et al., &amp; Freyer, DR (2023). Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial. <i>Clinical cancer research : an official journal of the American Association for Cancer Research</i> 29(13) 2410–2418. DOI:<a href=&quot;https://doi.org/10.1158/1078-0432.CCR-23-0252&quot;>10.1158/1078-0432.CCR-23-0252</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37134194/&quot;>https://pubmed.ncbi.nlm.nih.gov/37134194</a></p></li><li><p>Chabrot, P, et al., &amp; Abergel, A (2012). Cisplatin pharmacokinetics in nontumoral pig liver treated with intravenous or transarterial hepatic chemoembolization. <i>Cardiovascular and interventional radiology</i> 35(6) 1467–1474. DOI:<a href=&quot;https://doi.org/10.1007/s00270-012-0386-0&quot;>10.1007/s00270-012-0386-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22526107/&quot;>https://pubmed.ncbi.nlm.nih.gov/22526107</a></p></li><li><p>Obata, H, et al., &amp; Zhang, MR (2022). Precise quantitative evaluation of pharmacokinetics of cisplatin using a radio-platinum tracer in tumor-bearing mice. <i>Nuclear medicine communications</i> 43(11) 1121–1127. DOI:<a href=&quot;https://doi.org/10.1097/MNM.0000000000001614&quot;>10.1097/MNM.0000000000001614</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36120823/&quot;>https://pubmed.ncbi.nlm.nih.gov/36120823</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end L01XA01;
